Strides Pharma Science Announcements
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Strides Pharma Inc receives USFDA closure report (EIR)...
05 Feb, 2026 | 11:07am • Source: NSE
Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New YorkInspection included Drug Device Combinations covering our recent filing...
05 Feb, 2026 | 08:54am • Source: BSE
Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New YorkInspection included Drug Device Combinations covering our recent filing...
05 Feb, 2026 | 08:45am • Source: BSE
Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
03 Feb, 2026 | 04:52pm • Source: BSE
Response to BSE Query dated Feb 1, 2026 reference no. L/SURV/ONL/PV/APJ/2025-26/889
02 Feb, 2026 | 11:54am • Source: BSE
The Exchange has sought clarification from Strides Pharma Science Ltd on February 01, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
01 Feb, 2026 | 12:42pm • Source: BSE
Newspaper Advertisement - Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
31 Jan, 2026 | 03:49pm • Source: BSE
Outcome of Board meeting - Financial Results Q3 FY 2026
30 Jan, 2026 | 01:00pm • Source: BSE
Strides Press release on Q3 FY 26 financials
30 Jan, 2026 | 12:56pm • Source: BSE
Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2,359 million in Q3 FY26
30 Jan, 2026 | 12:54pm • Source: BSE
Unaudited financial results for quarter and nine months ended December 31, 2025
30 Jan, 2026 | 12:49pm • Source: BSE
Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, received from RTA of the Company
14 Jan, 2026 | 03:07pm • Source: BSE
Completion of US-FDA Inspection at Formulations Facility of Strides Pharma Inc.
24 Dec, 2025 | 06:34pm • Source: BSE
Intimation regarding closure of trading window for the quarter and nine months ended December 31, 2025
22 Dec, 2025 | 05:55pm • Source: BSE
Intimation under reg 30 - Resignation of Group CHRO
03 Dec, 2025 | 11:47am • Source: BSE
Schedule of Analyst/ Institutional Investor''s Meet
17 Nov, 2025 | 06:01pm • Source: BSE
Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025
05 Nov, 2025 | 03:35pm • Source: BSE
Newspaper advertisement - Unaudited financial results of the Company for the quarter and half year ended September 30, 2025
01 Nov, 2025 | 04:15pm • Source: BSE
Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2025
31 Oct, 2025 | 08:56pm • Source: BSE
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever...
31 Oct, 2025 | 01:53pm • Source: NSE